Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2023

May 5, 2023

31799_dirs_2023-05-05_f8256ed1-2fe6-472f-9006-ccd945f0414a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2023-05-03

Reporting Person: ZERBE ROBERT L MD (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-03 Stock Option (right to buy) $32.12 A 8000 Acquired 2033-05-03 Common Stock (8000) Direct
2023-05-03 Restricted Stock Unit $ A 3200 Acquired Common Stock (3200) Direct

Footnotes

F1: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.

F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.

F3: These RSUs vest 100% on the earlier of May 3, 2024 or the date of the first Annual Meeting of Stockholders following May 3, 2023.

F4: No expiration date for this type of award.